Home / Inspections / 1053519

FDA Inspection 1053519 — Boehringer Ingelheim Pharma GmbH & Co. KG

Boehringer Ingelheim Pharma GmbH & Co. KG — FEI 3002806556

The FDA completed an inspection of Boehringer Ingelheim Pharma GmbH & Co. KG on May 4, 2018 in Ingelheim am Rhein. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 4, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ingelheim am Rhein (Germany)

Facility

Other inspections at this facility

  • 1315938 (VAI Thu May 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1208521 (VAI Thu Oct 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 962108 (VAI Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 921540 (NAI Fri Jan 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 877010 (VAI Fri Mar 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources